Outcome of Board Meeting

October 12, 2026 BSE Limited National Stock Exchange of India Limited Floor 25, P. J. Towers Exchange Plaza Dalal Street, Fort Bandra Kurla Complex, Bandra (E) Mumbai - 400 001 Mumbai - 400 051 Scrip Code: 530019 Symbol: JUBLPHARMA Sub: Outcome of the Board meeting held on October 12, 2026 pursuant to the provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”) - Issuance of Secured / Unsecured, Listed, Rated, Redeemable Non-Convertible Debentures (NCDs) on Private Placement Basis - Regulation 30 of the SEBI Listing Regulations Dear Sir/Madam, Pursuant to Regulation 30 read with Schedule III of the SEBI Listing Regulations, we hereby inform that the Board of Directors of the Company, at its meeting held today, i.e., October 12, 2026, has, inter alia, considered and approved the following: 1. Issuance of Non-Convertible Debentures on a Private Placement Basis Issuance of up to 80,000 (Eighty Thousand) fully paid-up, rupee denominated, secured / unsecured, listed, rated, redeemable and transferable non-convertible debentures of face value of ₹1,00,000 each, aggregating up to ₹800 crore, on a private placement basis, in one or more tranches, subject to applicable laws and regulatory approvals, if any. 2. Approval to Seek Members' Authorization for Issuance of Non-Convertible Debt Securities on a Private Placement Basis Seeking approval of the members of the Company by way of a Special Resolution through Postal Ballot for issuance of non-convertible debt securities on a private placement basis, as per applicable provisions of the Companies Act, 2013 read with the SEBI Regulations, for an aggregate amount not exceeding ₹2,500 crore outstanding at any point of time, during a period of one year from the date of passing of the Special Resolution. The disclosure required under Regulation 30 of the SEBI Listing Regulations read with SEBI Master Circular no. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 are enclosed herewith as Annexure A. The meeting commenced at 11:00 A.M. and concluded at 12:15 P.M. The above mentioned documents will be simultaneously posted on the Company's website at www.jubilantpharmova.com. You are requested to kindly take the same on record. Thanking you, Yours faithfully, For Jubilant Pharmova Limited Naresh Kapoor Company Secretary Encl.: As above Annexure - A Type of securities proposed to Non-Convertible Debentures (NCDs), secured / unsecured, rated, be issued listed, redeemable non-convertible debentures (viz. equity shares, convertibles etc.); Type of issuance (further Private Placement basis public offering, rights issue, depository receipts (ADR/GDR), qualified institutions placement, preferential allotment etc.) Total number of securities Up to 80,000 fully paid-up, rupee denominated, secured / proposed to be issued or the unsecured, listed, rated, redeemable and transferable NCDs of total amount for which the face value of ₹1,00,000 each, aggregating up to ₹800 crore, to be securities will be issued issued in one or more tranches. (approximately); Size of the Issue Whether proposed to be Yes. The NCDs are proposed to be listed on Bombay Stock listed? If yes, name of the stock Exchange Limited (BSE) exchange(s) Tenure of the instrument - Upto five years from the Deemed Date of Allotment date of allotment and date of maturity Coupon / interest offered, Coupon/ interest offered: As may be discovered during the bidding schedule of payment of process coupon/interest and Principal Schedule of payment of coupon/interest and principal: Coupon/interest Payment Frequency: Annually, monthly or early redemption date as applicable. Charge / security, if any, As may be prescribed in KID created over the assets Special right / interest / As may be specified in the relevant Information privileges attached to the Memorandum/Key Terms of the issue instrument and changes thereof Delay in payment of interest / As may be specified in the relevant Information Memorandum/ principal amount for a period KID of more than three months from the due date or default in payment of interest / principal Details of any letter or Not Applicable comments regarding payment/non-payment of interest, principal on due dates, or any other matter concerning the security and / or the assets along with its comments thereon, if any Details of redemption of Not Applicable preference shares indicating the manner of redemption (whether out of profits or out of fresh issue) and debentures;